Q3 and FY consensus estimates
Estimates for Q3 and FY 2019/20 based on median.
| Q3 2019/20 | FY 2019/20 | |||||||
| DKKm | Low | Consensus | High | Low | Consensus | High | ||
| Revenue |
904 |
1,001 | 1,099 | 3,614 | 3,686 | 3,781 | ||
| Gross profit |
549 |
619 | 679 |
2,203 |
2,278 | 2,376 | ||
| Gross margin |
59.8% |
61.8% | 63.0% |
60.5% |
61.4% | 63.0% | ||
| EBIT before special items |
111 |
143 | 235 | 433 | 504 | 569 | ||
| EBIT margin before special items |
11.8% |
14.5% | 21.4% | 11.9% | 13.6% | 15.2% | ||
| Net profit |
78 |
96 | 170 | 267 | 322 | 406 | ||
| Net profit margin |
7.6% |
9.6% | 15.5% | 7.3% | 8.8% | 10.8% | ||
| Endoscopes sold (units) | 270,000 | 327,500 | 450,000 |
1,042,447 |
1,114,133 | 1,181,500 | ||
| Organic growth | 16% | 28% | 42% |
27% |
29% | 35% |
13 August 2020, based on estimates from 12 analysts.
